000 | 01236 a2200313 4500 | ||
---|---|---|---|
005 | 20250513112810.0 | ||
264 | 0 | _c19970326 | |
008 | 199703s 0 0 eng d | ||
022 | _a0007-1331 | ||
024 | 7 |
_a10.1046/j.1464-410x.1997.06310.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKreis, W | |
245 | 0 | 0 |
_aUnique synergism or antagonism of combinations of chemotherapeutic and hormonal agents in human prostate cancer cell lines. _h[electronic resource] |
260 |
_bBritish journal of urology _cFeb 1997 |
||
300 |
_a196-202 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xantagonists & inhibitors |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xantagonists & inhibitors |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 |
_aEstramustine _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
650 | 0 | 4 | _aTumor Cells, Cultured |
700 | 1 | _aBudman, D R | |
700 | 1 | _aCalabro, A | |
773 | 0 |
_tBritish journal of urology _gvol. 79 _gno. 2 _gp. 196-202 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1464-410x.1997.06310.x _zAvailable from publisher's website |
999 |
_c9040632 _d9040632 |